PAR · Par Drugs And Chemicals Ltd · Biotechnology & Drugs
PAR · Par Drugs And Chemicals Ltd · Biotechnology & Drugs
As of 05 Nov close
52-week range
37.9% below 52-week high
52-week range: as of 05 Nov 2026 close.
Price chartDaily closes on the stock page.
Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.
Full signal detail →Fundamentals as of 16 Oct 2026
Revenue (latest Q)
₹31 Cr
Revenue YoY
PAT YoY
+41.4%
Operating margin
Revenue, last 8 quarters
P/E (TTM)
P/B
1.2
P/S (TTM)
1.3
Sector P/E
33.6
Dividend yield
0.0%
| Company | P/E | P/B | Net margin | ROE | D/E | Div. yield |
|---|---|---|---|---|---|---|
| PAR (this stock) | 7.6 | 1.2 | +13.3% | +12.9% | 0 | 0.0% |
| Sun Pharmaceutical Industries | 38.4 | 5.6 | +19.1% | +14.2% | 0.47 | +0.8% |
| Divi's Laboratories | 59.7 | 14.5 | +26.1% | +17.4% | 0 | +0.3% |
| Torrent Pharmaceuticals | 72.7 | 19.2 | +15.3% | +27.1% | 141.16 | +0.8% |
Promoter
stable
FII
falling 1q
MF
Not available from data source
Insider trades
No insider trades in the last 12 months.
Bulk/block deals
| date | canonicalSymbol | buy quantity | buyer count | deal strength | deal types present |
|---|---|---|---|---|---|
| 2026-09-02 | PAR | 185156 | 2 | STRONG | BULK |
News timeline
No related news.
Concalls & investor presentations
AI-generatedNo concall transcripts or investor presentations recorded yet.
AI Summary of Annual Report
AI-generatedPar Drugs and Chemicals Limited's annual report for FY2025-26 highlights the company's focus on corporate governance, sustainability initiatives, and adherence to regulatory requirements. The report outlines the company's commitment to maintaining strong internal controls, transparent stakeholder communication, and ethical business practices. It also details recent CSR activities, including infrastructure development for education and environmental sustainability projects, while acknowledging ongoing regulatory processes and market challenges impacting profitability.
- Emphasis on corporate governance with structured board committees and compliance frameworks.
- Implementation of sustainability initiatives such as solar power installation and CSR projects focused on education and environmental impact.
- Adherence to regulatory requirements and cooperation with competent authorities during ongoing processes.
- Focus on internal control systems to ensure financial reporting and asset safeguarding.
Key takeaway: The company prioritizes robust corporate governance, sustainability, and regulatory compliance, while navigating market challenges through strategic internal controls and stakeholder engagement.
The following annual report excerpts provide qualitative strategic context. Do not treat any specific financial figures in these excerpts as authoritative — they may be incorrectly labeled due to PDF table extraction limitations. For precise financial data, refer to the structured fundamentals data above.
Governance disclosures
AI-generatedNeeds attention
Regulatory Action (1 item)
Items of these kinds are disclosed in the filings. This is a count of disclosed items. It is not a finding about the company and its cause has not been independently established.
Regulatory Action
1 occurrenceEarlier (1-3 years ago)
The company faced a regulatory action from the National Stock Exchange for a 2-day delay in submitting financial results for the quarter and nine months ended 31 December 2023, and paid a fine imposed by NSE.
Routine disclosures
Contingent Liability
1 occurrenceEarlier (1-3 years ago)
The company has contingent liabilities related to claims not acknowledged as debts, bank guarantees issued by Kotak Mahindra Bank, and bills discounted from banks.
Related-Party Transaction
1 occurrenceEarlier (1-3 years ago)
The company entered into a related party transaction worth Rs. 27 Crore in the Clean energy market and Rs. 41 Crore in the Capital market, which was approved by members via a special resolution passed in an Extra Ordinary General Meeting on 12th February, 2025. The transaction is expected to complete between 30th September, 2025, and 31st December, 2025, and is proposed to be a one-time transaction.
Management & Board Governance
1 occurrenceEarlier (1-3 years ago)
Ghanshyambhai B Savani, a former Whole-time Director, resigned on January 15, 2025.